期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | MOLECULAR CANCER THERAPEUTICS LetPub Score 7.9
50 ratings
Rate
Reputation 8.8 Influence 6.7 Speed 9.6 | ||||||||||||||||||||
期刊簡稱 | MOL CANCER THER | ||||||||||||||||||||
ISSN | 1535-7163 | ||||||||||||||||||||
E-ISSN | 1538-8514 | ||||||||||||||||||||
h-index | 157 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://mct.aacrjournals.org/ | ||||||||||||||||||||
在線稿件提交 | http://mct.msubmit.net/cgi-bin/main.plex | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | American Association for Cancer Research Inc. | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 2001 | ||||||||||||||||||||
每年文章數 | 116每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 32.75% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1535-7163%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 3 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[MOLECULAR CANCER THERAPEUTICS] 的評論 | 撰寫評論 |
作者: Xiong— 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-07-02 22:39:07 評論於 The first trial takes one and a half months, two months for revision, and the second trial is accepted within one week.(0) 讚! | Xiong— |
作者: Yvonne Zhan 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-07-02 22:12:26 評論於 The magazine under the American Cancer Society has fewer publications by Chinese people, making it more difficult to submit. The reviewers provide constructive feedback, and making improvements according to their suggestions has enhanced the experimental articles.(0) 讚! | Yvonne Zhan |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 08:52:15 評論於 The majority of journals use online submissions. Authors need to prepare the manuscript, tables, and attachments in advance. The submission process generally follows: go to the journal's website, open "submit paper", register an account as the corresponding author, then login as an author, follow the instructions, download the pdf, ensure accuracy, and submit(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 08:00:37 評論於 Most journals require submissions in Word format, but there are also some that request PDF(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 19:21:00 評論於 Should I upload the article in Word or PDF format?(0) 讚! | 北国博达 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 23:56:33 評論於 How should an article be uploaded?(0) 讚! | 破戒阳平 |
作者: Paula Rayleign 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-31 13:34:19 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Emphasized research direction: experience sharing in cancer metastasis research: original images need to be uploaded. The review speed is okay, and reviewers are fair. Although not as good as the top journals, AACR's journal is still trustworthy(0) 讚! | Paula Rayleign |
作者: yi----- 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-03-18 23:44:31 評論於 First review took one month, second review took one and a half months. From submission to online publication, it took a total of eight months (07/2020 - 03/2021).(0) 讚! | yi----- |
作者: 擒龙俊鑫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-06-27 10:40:43 評論於 Excuse me, there is a big difference between target protein and internal reference, it's wasteful to use one membrane for antibody blotting, so I cut the membrane before antibody blotting. Is this okay?(0) 讚! | 擒龙俊鑫 |
作者: Donna Hodge 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-14 10:56:40 評論於 Review speed: 6.0 | Submission success rate: 25.0 Experience sharing: Too long(0) 讚! | Donna Hodge |
作者: 帕梅拉潘兹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-06-30 18:50:57 評論於 Color pictures are more expensive. I have a figure of 6, with 2 black and white pictures and 4 color pictures. One color picture costs $625, and the publication fee is $1200(0) 讚! | 帕梅拉潘兹 |
作者: 重阳欣悦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-06-16 08:24:52 評論於 Hello, may I ask how much is the layout fee for the magazine?(0) 讚! | 重阳欣悦 |
作者: Bevis Bart 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-06-05 10:46:40 評論於 Basically, no magazine will require three results. The reason is well known to everyone. The magazines also know that if they require three results, no one will submit. I don't know about the CNS journal, but sub-journals only require results once. The current wb requires uncropped film, and the editor will ask for it before acceptance(0) 讚! | Bevis Bart |
作者: 重阳泰宁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-05-23 12:00:39 評論於 Review speed: 2.0 | Submission hit rate: 25.0 Experience sharing: What original data needs to be provided? Are the results of the wb three times needed? When to provide? Do you need to submit as is or after modification?(0) 讚! | 重阳泰宁 |
作者: 帕梅拉潘兹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-04-29 21:16:10 評論於 Review speed: 1.0 | Submission hit rate: 25.0 Experience sharing: Just received a manuscript. First submission in June, rejected without external review, but was told that it could be resubmitted with additional experiments; submitted again in July after the completion of the experiments, rejected again, and was told that relevant sequences must be provided for external review; resubmitted in mid-September, external review comments received on October 30, minor revisions, and returned after 2 months of revision. Revised on January 7, 2019, officially accepted on April 26(0) 讚! | 帕梅拉潘兹 |
作者: 傲寒曼吟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-03-31 21:53:38 評論於 It's been ten days. How are you feeling now?(0) 讚! | 傲寒曼吟 |
作者: 东风谷宏帅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-03-20 18:11:03 評論於 It has been several days since the quality control, but there have been no changes. Has anyone else experienced this situation?(0) 讚! | 东风谷宏帅 |
作者: 东风谷宏帅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-03-15 13:59:44 評論於 How did your QC issue turn out in the end? I also encountered a similar issue, is it normal?(0) 讚! | 东风谷宏帅 |
作者: Bevis Bart 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-02-14 08:38:22 評論於 It's a big loss for CCR to switch to this one downstairs(0) 讚! | Bevis Bart |
作者: Blithe Bell 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-30 19:46:34 評論於 Do you need the original uncropped image of WB?(0) 讚! | Blithe Bell |
作者: Barton Frances 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-13 22:39:21 評論於 May I ask, classmates: how is the fate of your article?(0) 讚! | Barton Frances |
作者: 玉霄飞翮 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-13 12:03:18 評論於 The article was rejected the day after being under review at CCR, then they resubmitted to another journal and it has been 9 days. How long does this journal usually take to send for external review, or to reject in the first round?(0) 讚! | 玉霄飞翮 |
作者: 玄虚书仪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-11-06 22:45:31 評論於 Excuse me, has QC7 been released already? Is it normal? Do we still need to pay the submission fee for the magazine? Where can we find it?(0) 讚! | 玄虚书仪 |
作者: 风啸涵博 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-10-27 15:00:40 評論於 An apple declared itself a planet on 2018-09-26 00:00:00 and asked: Does this magazine charge for placement?(0) 讚! | 风啸涵博 |
作者: 逸轩少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-26 22:32:15 評論於 High demands are placed on data, editors require original, uncut Western blot bands(0) 讚! | 逸轩少爷 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us